268 related articles for article (PubMed ID: 26221190)
1. Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas.
Lee JJ; Sholl LM; Lindeman NI; Granter SR; Laga AC; Shivdasani P; Chin G; Luke JJ; Ott PA; Hodi FS; Mihm MC; Lin JY; Werchniak AE; Haynes HA; Bailey N; Liu R; Murphy GF; Lian CG
Clin Epigenetics; 2015; 7(1):59. PubMed ID: 26221190
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation in human melanoma: past and future.
Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
[TBL] [Abstract][Full Text] [Related]
3. Emerging role of mutations in epigenetic regulators including MLL2 derived from The Cancer Genome Atlas for cervical cancer.
Li X
BMC Cancer; 2017 Apr; 17(1):252. PubMed ID: 28390392
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic markers in melanoma.
Guo W; Xu T; Lee JJ; Murphy GF; Lian CG
Melanoma Manag; 2015 Nov; 2(4):367-382. PubMed ID: 30190864
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical loss of 5-hydroxymethylcytosine expression in acute myeloid leukaemia: relationship to somatic gene mutations affecting epigenetic pathways.
Magotra M; Sakhdari A; Lee PJ; Tomaszewicz K; Dresser K; Hutchinson LM; Woda BA; Chen BJ
Histopathology; 2016 Dec; 69(6):1055-1065. PubMed ID: 27458708
[TBL] [Abstract][Full Text] [Related]
6. A meta-analysis of somatic mutations from next generation sequencing of 241 melanomas: a road map for the study of genes with potential clinical relevance.
Xia J; Jia P; Hutchinson KE; Dahlman KB; Johnson D; Sosman J; Pao W; Zhao Z
Mol Cancer Ther; 2014 Jul; 13(7):1918-28. PubMed ID: 24755198
[TBL] [Abstract][Full Text] [Related]
7. Clonal architectures and driver mutations in metastatic melanomas.
Ding L; Kim M; Kanchi KL; Dees ND; Lu C; Griffith M; Fenstermacher D; Sung H; Miller CA; Goetz B; Wendl MC; Griffith O; Cornelius LA; Linette GP; McMichael JF; Sondak VK; Fields RC; Ley TJ; Mulé JJ; Wilson RK; Weber JS
PLoS One; 2014; 9(11):e111153. PubMed ID: 25393105
[TBL] [Abstract][Full Text] [Related]
8. TET2 as an epigenetic master regulator for normal and malignant hematopoiesis.
Nakajima H; Kunimoto H
Cancer Sci; 2014 Sep; 105(9):1093-9. PubMed ID: 25040794
[TBL] [Abstract][Full Text] [Related]
9. The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma.
Zhao X; Little P; Hoyle AP; Pegna GJ; Hayward MC; Ivanova A; Parker JS; Marron DL; Soloway MG; Jo H; Salazar AH; Papakonstantinou MP; Bouchard DM; Jefferys SR; Hoadley KA; Ollila DW; Frank JS; Thomas NE; Googe PB; Ezzell AJ; Collichio FA; Lee CB; Earp HS; Sharpless NE; Hugo W; Wilmott JS; Quek C; Waddell N; Johansson PA; Thompson JF; Hayward NK; Mann GJ; Lo RS; Johnson DB; Scolyer RA; Hayes DN; Moschos SJ
Front Oncol; 2018; 8():584. PubMed ID: 30662871
[No Abstract] [Full Text] [Related]
10. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract][Full Text] [Related]
11. Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer.
Wen S; Dai L; Wang L; Wang W; Wu D; Wang K; He Z; Wang A; Chen H; Zhang P; Dong X; Dong YA; Wang K; Yao M; Wang M
Oncologist; 2019 Nov; 24(11):e1070-e1081. PubMed ID: 30902917
[TBL] [Abstract][Full Text] [Related]
12. Isocitrate dehydrogenase 1 mutations in melanoma frequently co-occur with NRAS mutations.
Linos K; Tafe LJ
Histopathology; 2018 Dec; 73(6):963-968. PubMed ID: 30003571
[TBL] [Abstract][Full Text] [Related]
13. Anchored Multiplex PCR Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA.
Diefenbach RJ; Lee JH; Stewart A; Menzies AM; Carlino MS; Saw RPM; Stretch JR; Long GV; Scolyer RA; Rizos H
Front Oncol; 2022; 12():820510. PubMed ID: 35494035
[TBL] [Abstract][Full Text] [Related]
14. Mutation of epigenetic regulators TET2 and MLL3 in patients with HTLV-I-induced acute adult T-cell leukemia.
Yeh CH; Bai XT; Moles R; Ratner L; Waldmann TA; Watanabe T; Nicot C
Mol Cancer; 2016 Feb; 15():15. PubMed ID: 26880370
[TBL] [Abstract][Full Text] [Related]
15. Melanoma epigenetics: novel mechanisms, markers, and medicines.
Lee JJ; Murphy GF; Lian CG
Lab Invest; 2014 Aug; 94(8):822-38. PubMed ID: 24978641
[TBL] [Abstract][Full Text] [Related]
16. Epigenetics of malignant melanoma.
Moran B; Silva R; Perry AS; Gallagher WM
Semin Cancer Biol; 2018 Aug; 51():80-88. PubMed ID: 29074395
[TBL] [Abstract][Full Text] [Related]
17. The role of 5-hydroxymethylcytosine in melanoma.
Li FJ; Li LM; Zhang RH; Xu C; Zhou P; Long J; Hu G; Jiang MJ
Melanoma Res; 2017 Jun; 27(3):175-179. PubMed ID: 28225433
[TBL] [Abstract][Full Text] [Related]
18. Additional mutations in IDH1/2-mutated patients with acute myeloid leukemia.
Lu J; Chen M; Hua H; Qin W; Zhang R; Lu X; Chao H
Int J Lab Hematol; 2021 Dec; 43(6):1483-1490. PubMed ID: 34270876
[TBL] [Abstract][Full Text] [Related]
19. Age-related next-generation sequencing mutational analysis in 1196 melanomas.
Santamaria-Barria JA; Matsuba C; Khader A; Scholar AJ; Garland-Kledzik M; Fischer TD; Essner R; Salomon MP; Mammen JMV; Goldfarb M
J Surg Oncol; 2023 Jun; 127(7):1187-1195. PubMed ID: 36938777
[TBL] [Abstract][Full Text] [Related]
20. Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study.
Casula M; Paliogiannis P; Ayala F; De Giorgi V; Stanganelli I; Mandalà M; Colombino M; Manca A; Sini MC; Caracò C; Ascierto PA; Satta RR; ; Lissia A; Cossu A; Palmieri G;
BMC Cancer; 2019 Aug; 19(1):772. PubMed ID: 31382929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
